Progyny Inc 's Revenue in the fiscal year 2025 $ 1,288.48 millions
Progyny Inc 's Revenue in the fiscal year 2024 $ 1,166.36 millions
Progyny Inc 's Revenue in the fiscal year 2023 $ 1,087.80 millions
Progyny Inc 's Revenue in the fiscal year 2022 $ 786.91 millions
Progyny Inc 's Revenue in the fiscal year 2021 $ 500.62 millions
PGNY Revenue second quarter 2026 Y/Y Growth Comment
Progyny Inc reported Revenue growth of 5.59% year on year in the second quarter 2026, to $ 350.51 millions, this is lower than Progyny Inc 's recent average Revenue rise of 48.75%.
Looking into second quarter 2026 results within Healthcare Facilities industry 24 other companies have achieved higher Revenue growth. While Progyny Inc ' s Revenue increase of 5.59% ranks overall at the positon no. 2316 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Progyny Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
61.71 %
9.36 %
-20.26 %
(Mar 31 2019)
PGNY's II. Quarter Q/Q Revenue Comment
Progyny Inc achieved in the II. Quarter 2026 below company average Revenue increase of 6.84% quarter on quarter, to $ 350.51 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.52% in the II. Quarter a year ago.
Within Healthcare Facilities industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Progyny Inc 's Revenue growth quarter on quarter, overall rank is 985.
Progyny Inc achieved in the II. Quarter 2026 below company average Revenue increase of 6.84% quarter on quarter, to $ 350.51 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.52% in the II. Quarter a year ago.
Within Healthcare Facilities industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Progyny Inc 's Revenue growth quarter on quarter, overall rank is 985.
Progyny Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 1,311.30
$ 1,292.76
$ 1,288.48
$ 1,268.04
$ 1,241.44
Y / Y Revenue Growth (TTM)
5.63 %
6.6 %
10.47 %
11.52 %
9.72 %
Year on Year Revenue Growth Overall
Ranking
# 1487
# 1265
# 1445
# 497
# 620
Seqeuential Revenue Change (TTM)
1.43 %
0.33 %
1.61 %
2.14 %
2.37 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2316
# 1816
# 1938
# 1019
# 1858
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Progyny Inc 's cumulative twelve months Revenue were $ 1,311 millions, company would post below average annual Revenue growth of 2.37% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Progyny Inc 's Revenue growth from the 328.07% growth in Mar 31 2026.
In the Healthcare sector 250 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1265 to 1487.
With the quarterly Revenue reported in the Jun 30 2026 period, Progyny Inc 's cumulative twelve months Revenue were $ 1,311 millions, company would post below average annual Revenue growth of -9.18% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Progyny Inc 's Revenue growth from the 328.07% growth in Mar 31 2026.
In the Healthcare sector 250 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1265 to 1487.
About Progyny Inc Revenue Growth Rates (PGNY), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
9.73%